Diagnostic imaging matters


Acknowledgment This review was developed by Succinct Healthcare Communications with editorial assistance from GE Healthcare.


References 1. Davidson C, Stacul F, McCullough PA et al. Contrast medium use. Am J Cardiol 2006; 98 (Suppl 1): 42–58.


2. Katzberg RW. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997; 204: 297–312.


3. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68: 14–22.


4. Persson PB, Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Kidney Int Suppl 2006; 100: S8–210.


5. Seeliger E, Flemming B, Wronski T et al. Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol 2007; 18: 2912–2920.


6. Jost G, Pietsch H, lengsfeld P, Hutter J, Sieber MA. The impact of the viscosity and osmolality of iodine contrast agents on renal elimination. Invest Radiol 2010; 45: 255–261.


7. Kirby BJ. Micro- and nanoscale fluid mechanics: transport in microfluidic devices. Available at: http://www. kirbyresearch.com/textbook (accessed August 2011).


8. Bae KT. Intravenous contrast medium administration and scan timing at CT: considerations and approaches. Radiology 2010; 256: 32–61.


9. Dyvik K, Dyrstad K, Tronstad A. Relationship between viscosity and determined injection pressure in angiography catheters for common roentgen contrast media. Acta Radiol Suppl 1995; 399: 43–49.


10. Berg KJ, Jakobsen JA. Renal tolerance of nonionic dimers in humans: how relevant are experiments in rats? Invest Radiol 1997; 32: 368–370.


11. Rasmussen F, Lindequist S, Nielsen SM, Bjartveit K. Renal CT after intravenous injection of nonionic dimeric or nonionic monomeric contrast media in healthy volunteers. Acta Radiol 1997; 38: 61–67.


12. Liss P, Persson PB, Hansell P, Lagerqvist B. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006; 70: 1811–1817.


13. Jo SH, Koo BK, Youn TJ, Kim HS. Iodixanol vs ioxaglate for preventing contrast nephropathy: who is winner? Kidney Int 2007; 71: 828–829.


14. Jakobsen JÅ, Lundby B, Kristoffersen DT, Borch KW,


Hald JK, Berg KJ. Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers. Radiology 1992; 182: 419–424.


15. Jakobsen JÅ. Renal experience with visipaque. Eur Radiol 1996; 6 (Suppl 2): S16–S19.


16. Moreau JF, Droz D, Sabto J et al. Osmotic nephrosis induced by water-soluble triiodinated contrast media in man: A retrospective study of 47 cases. Radiology 1975; 115: 329–336.


17. Moreau JF, Droz D, Noel LH, Leibowitch J, Jungers P, Michel JR. Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 1980; 15 (Suppl): S54–S60.


18. Andersen KJ, Vik H, Eikesdal HP, Christensen EI. Effects of contrast media on renal epithelial cells in culture. Acta Radiol Suppl 1995; 399: 213–218.


19. Jakobsen JÅ. Renal effects of iodixanol in healthy volunteers and patients with severe renal failure. Acta Radiol Suppl 1995; 399: 191–195.


20. Jakobsen JÅ, Berg KJ, Kjærsgaard P et al. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention. Nephron 1996; 73: 549–556.


21. Tveit K, Bolz KD, Bolstad B et al. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. Acta Radiol 1994; 35: 614–618.


22. Kløw NE, Levorstad K, Berg KJ et al. Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol 1993; 34: 72–77.


23. Pugh ND, Sissons GR, Ruttley MS, Berg KJ, Nossen JO, Eide H. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 1993; 47: 96–99.


24. Fischbach R, Landwehr P, Lackner K et al. Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries: a comparative phase-III trial. Eur Radiol 1996; 6: 9–13.


25. Dobrota M, Powell CJ, Holtz E, Wallin A, Vik H. Biochemical and morphological effects of contrast media on the kidney. Acta Radiol Suppl 1995; 399: 196–203.


26. Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol 1999; 34: 685–691.


27. Jung F, Mrowietz C, Rickert D, Hiebl B, Park JW, Franke RP. The effect of radiographic contrast media on the morphology of human erythrocytes. Clin Hemorheol Microcirc 2008; 38: 1–11.


8


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12